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Abstract
Peroxisome proliferator-activated receptor α (PPARα) is critical for muscle endurance due
to its role in the regulation of fatty acid oxidation. The 5’-AMP-activated protein kinase
(AMPK) is an energy sensor in cells, but its role in PPARα regulation in vivo remains un-
known. In this study, we examined PPARα expression in the skeletal muscle of AMPKα2
overexpression (OE), knockout (KO) and wild-type (WT) mice after four weeks of exercise
under intermittent hypoxia. WT, OE and KOmice were used at 40 mice/strain and randomly
subdivided into four subgroups: control (C), running (R), hypoxia (H), and running plus hyp-
oxia (R+H) at 10 mice/group. The treadmill running was performed at the speed of 12 m/
min, 60 min/day with a slope of 0 degree for four weeks. The hypoxia treatment was per-
formed in daytime with normobaric hypoxia (11.20% oxygen, 8 hours/day). In the R+H
group, the treadmill running was conducted in the hypoxic condition. AMPKα2, phosphor-
AMPKα (p-AMPKα) (Thr172), nuclear PPARα proteins were measured by Western blot and
the medium chain acyl coenzyme A dehydrogenase (MCAD) mRNA, the key enzyme for
fatty acid oxidation and one of the PPARα target genes, was also measured in skeletal mus-
cles after the interventions. The results showed that nuclear PPARα protein was significant-
ly increased by R+H in WTmuscles, the increase was enhanced by 41% (p<0.01) in OE
mice, but was reduced by 33% (p<0.01) in KO mice. The MCADmRNA expression was in-
creased after four weeks of R+H intervention. The change in MCADmRNA followed a simi-
lar trend as that of PPARα protein in OE and KO mice. Our data suggest that the increase in
nuclear PPARα protein by four-week exercise training under the intermittent hypoxia was
dependent on AMPK activation.
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Introduction
Hypoxic training (combination of exercise and hypoxia) has been known to increase the en-
durance capacity of skeletal muscles in athletes [1,2]. Several studies have shown that hypoxic
training improved the 5’-AMP-activated protein kinase (AMPK) and glucose transporter 4
(GLUT4) pathway to enhance glucose metabolism and mitochondrial function in the skeletal
muscle of human or rats [3–5]. Considered of promoting aerobic metabolism of skeletal muscle
and improving athlete performance, it is important to investigate the molecular mechanism by
which hypoxic training affects skeletal muscle.
Peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription
factor that belongs to the steroid hormone receptor superfamily [6]. PPARα is abundantly ex-
pressed in tissues with high fatty acid catabolism, such as liver, heart, and skeletal muscle [7],
and is predominantly localized in the nucleus [8]. Over the last several decades, there have
been many studies on the physiology, pharmacology, and functional genomics of PPARα. Both
in vivo and in vitro studies have demonstrated that PPARα regulates the expression of some
genes involved in lipid metabolism and plays a central role in the control of dyslipidemia asso-
ciated with the metabolic syndrome [9–11].
PPARαmay play an important role in exercise endurance. It has been reported that PPARα
involved in the transcriptional regulation of metabolic enzymes and increased fatty acid oxida-
tion in muscle tissues after endurance exercise training [12,13]. However, a down-regulation of
PPARα protein was reported in skeletal muscle after a short-term (i.e. for a few hours to seven
days) exercise in a normobaric hypoxic condition [14]. It remains unknown what happens to
PPARα after long-term exercise in hypoxia, though the effects of long-term intermittent hyp-
oxia alone on muscle performance has attracted much attention [15,16].
AMPK is an intracellular energy sensor that controls glucose and lipid metabolism, espe-
cially in skeletal muscles [17,18]. AMPK is a heterotrimeric kinase that contains two regulato-
ry subunits (β and γ), and one catalytic subunit (α including α1 and α2). AMPK is activated
in skeletal muscle during exercise to enhance ATP production through the phosphorylation
of α subunit at Thr172 residue [19]. The role of PPARα in AMPK signaling pathway was in-
vestigated in a few studies in cellular models but the results of which were not conclusive. A
study suggested that AMPKα activated PPARα in rat hepatocytes [20]. Another study re-
ported that the activation of AMPK with 5-aminoimidazole-4-carboxamide ribonucleotide
(AICAR), a well-established AMPK activator, increased PPARα activity in mouse skeletal
muscle [21]. However, it was also reported that AMPK activation by AICAR reduced the
transcriptional activity of PPARα in rat hepatoma cells [22]. In a review article, Leff cited un-
published data about inhibition of PPARα by AICAR [23]. These studies were all conducted
in vitro, and the data have shown contradicting effects of AMPK on PPARα. To the best of
our knowledge, there is no in vivo study to determine AMPK activation in the regulation of
PPARα in skeletal muscle so far.
The purpose of the present study was to determine the role of AMPKα in the regulation of
PPARα in skeletal muscle, through in vivo testing. PPARα protein and its target gene expres-
sion of medium chain acyl coenzyme A dehydrogenase (MCAD) mRNA (the key enzyme for
fatty acid oxidation) were examined in AMPKα2 overexpression (OE) and AMPKα2 knockout
(KO) mice (C57BL/6J) after four weeks of exercise training in normoxia or intermittent hypox-
ia. We tested the hypothesis of intermittent hypoxic training would achieve the stronger ex-
pressions of nuclear PPARα protein and its target gene compared to that of hypoxia or
running only in mouse skeletal muscle; and the increases in all these expressions would be asso-
ciated with AMPK activation.
AMPKα2 and PPARα in Muscle
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Materials and Methods
Animal models
WT C57BL/6J mice and AMPKα2 OE mice were provided by the Institute of Laboratory Ani-
mal Science of Peking Union Medical College. The detailed method of the OE mice generation
was described in our previous paper [24]. The AMPKα2 KO mice were kindly provided by Be-
noit Viollet (Department of Endocrinology, Metabolism and Cancer, Institute Cochin, Univer-
sity Paris Descartes, Paris, France) and bred by the Institute of Laboratory Animal Science of
Peking Union Medical College. The generation of KO mice was described in detailed in the lit-
erature [25]. The AMPKα2 KO and AMPKα2 OE mice were both in C57BL/6J gene back-
ground. GPower3 software (http://psycho.uniduesseldorf.de) was used to estimate the sample
size. We chose power = 0.95 with α set at 0.05 and 12 groups, selected F tests, ANOVA: fixed
effects, main effects and interactions, and then the result was computed to be seven mice per
group with effect size = 0.6. In this study, there were 40 WTmice, 40 AMPKα2 OE mice, and
40 AMPKα2 KO mice. 10 mice were in each group.
All mice were two months old with a mean body weight of 18±2 g. They were housed with
controlled room temperature (20–25°C), 12:12hr light—dark cycle and free access to food and
water. The study protocol was approved by the Animal Care and Use Committee of Beijing
Sport University, China.
Hypoxic training protocol
After allowing acclimatization to their housing, each strain of the mice were randomly divided
into four subgroups: control group (C), running group (R), hypoxia group (H), and running
plus hypoxia (R+H) at 10 mice/group.
There was a 3-day adaptive training session before the interventions. During this session,
the R and R+H groups run 15 minutes on a treadmill in day 1, 30 minutes in day 2, and 45
minutes in day 3, in normoxia or intermittent hypoxia, respectively. After the acclimation, the
R and R+H groups were subject to 60 min/day treadmill running for four weeks at the speed of
12 m/min, with a slope of 0 degree. This exercise intensity corresponded to about 76% of maxi-
mal oxygen uptake in mice [26]. The hypoxia was made by placing the mice in a normobaric
chamber (210 cm long, 200 cm wide, and 200 cm tall). The chamber was infused with 11.2%
oxygen air through an air compressor (Ingersoll Rand, USA) which was connected with a hyp-
oxic air machine. The oxygen concentration in the normobaric chamber was monitored
throughout the experimental period with an oxygen sensor equipped with an alarm. The hyp-
oxic treatment was 8 hours/day during daytime for four weeks. In the R+H group, mice com-
pleted the treadmill running in the normobaric hypoxic chamber. Before tissue collection, all
mice had a 16-hour recovery time after the last intervention [24,27] with free access to food
and water. The mice were euthanized by cervical dislocation and the quadriceps femoris mus-
cles were collected, cleaned and quick-frozen in liquid nitrogen, and then stored at -80°C.
Real-time PCR
Total RNA was isolated from about 50 mg of crushed muscle tissue using the TRI regent ac-
cording to the manufacturer’s instructions. Real-time PCR was performed in a ABI 7500 Real-
time PCR System (Life Technologies, USA) using the SYBR Green Real-time PCR Master Mix
kit (Toyobo, Japan) with the previously synthesized cDNA (FSQ-101 Toyobo, Japan) as tem-
plate in a 20μL reaction volume. Primers were used as follows: MCAD gene (QIAGEN,
QT00111244) and 18s gene [28] (QIAGEN, QT010036875), qualified by software (ABI 7500
RT PCR). The difference in expression between control and experimental samples was
AMPKα2 and PPARα in Muscle
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calculated as 2-ΔΔCT, as did in a previous study of our laboratory [24]. To assess the specificity
of the amplified PCR products, after the last cycle we performed a melting curve analysis and
subjected reaction end products to electrophoresis in 1% agarose gels and compared band in-
tensities by imaging of SYBR Green-stained gels.
Western blot analysis
Total proteins were isolated from 50 mg of muscle using T-PER tissue protein extraction re-
agents (78510, Pierce, Rockford, IL, USA). Nuclear proteins were isolated from 50 mg of mus-
cle using NE-PER nuclear extraction reagents (87792, Pierce, Rockford, IL, USA). Protein
concentration was measured using the BCA protein assay kit (23225, Pierce, Rockford, IL,
USA). After separated on a 10% SDS-PAGE by electrophoresis at 120 volts for 90 min, the frac-
tionated proteins were transferred to a nitrocellulose transfer membrane. The membrane was
blocked for 60 min in TBST (Tris-buffered saline with 0.10% Tween 20) containing 5% nonfat
milk (5% Bovine Serum Albumin) to block AMPKα1/α2-Thr172 phosphorylation. The sample
was then incubated overnight at 4°C using the following primary antibodies: anti-AMPKα2
(sc-19129, Santa Cruz Biotechnology, Santa Cruz, CA,USA), anti-phospho-AMPKα1/α2
(Thr172) (sc-33524, Santa Cruz, CA, USA), anti-PPARα (sc-9000, Santa Cruz, CA, USA), anti-
β-actin (sc-47778, Santa Cruz, CA, USA), and anti- Histone1 (sc-10806, Santa Cruz, CA,
USA). The membranes were then incubated with the appropriate anti-rabbit secondary anti-
body, diluted in TBST. Immunoreactive bands were highlighted by electrochemiluminescence
(ECL) technology, exposed to light sensitive film for 15–90 s, and quantified by densitometry
using image analysis software (Kodak Digital Science, New York, USA). The individual values
were originally expressed as a ratio of a target protein and an internal protein standard (target
protein content/internal protein content) and then expressed as a fold change of the normal
oxygen WT control group (target protein content/internal protein content) value.
Statistical analysis
Statistical calculations were performed using SPSS 13 (SPSS Inc., Chicago, IL, USA). A two-
way ANOVA (strain x intervention) was used to analyse all of the variables across the experi-
mental groups. The strain has three types: WT, OE, and KO. The intervention has four groups:
C, R, H, and R+H. When a significant interaction effect was obtained, the simple main effect
analysis with post-hoc (LSD test) was performed to identify significant mean differences be-
tween groups. A p value of 0.05 was considered statistically significant. The results were ex-
pressed as the means ± SD.
Results
AMPKα activation is induced by hypoxic training in skeletal muscle
AMPKα2 was over expressed and knocked out in the OE and KO mice, respectively. The ef-
fects of gene modification were proved by AMPKα2 protein levels in the skeletal muscle (Fig
1A). The protein was detected with the antibody to AMPK2α in WT mice, was significantly el-
evated in OE mice, but without detectable signal in KO mice.
As an indicator of AMPK activation, phosphor-AMPKα (p-AMPKα) (Thr172) was mea-
sured in the muscle samples by Western blot, using phosphor-specific antibody. The anti-
body is able to detect both α1 and α2 isoforms of AMPK, but cannot detect the β or γ
subunits of AMPK.
In WTmice, AMPK activation was significantly increased in skeletal muscle by treadmill
running as indicated by 24% (p<0.05) elevation over the control in phosphor-AMPK signal
AMPKα2 and PPARα in Muscle
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(Fig 1B and 1C). The AMPK activation was further enhanced by running in hypoxia for 41%
(p<0.01) increase in the phosphorylation signal. In OE mice, the basal phosphorylation signal
was same to that of WT mice (Fig 1B and 1C). However, OE mice showed 23% (p<0.05) and
40% (p<0.05) more AMPK phosphorylation than WTmice in the running and hypoxic run-
ning conditions, respectively. In KO mice, the protein of AMPKα2 was not detectable due to
gene knockout (Fig 1A), but the phosphorylation of AMPKα (AMPKα1/α2) was detected (Fig
1B). Phosphor-AMPKα was induced by running and hypoxic running (Fig 1B and 1C). How-
ever, the increases were 30% (p<0.01) and 34% (p<0.05) lower than those of WT mice in the
same conditions, respectively (Fig 1B and 1C).
Hypoxia alone did not change AMPK activation in WTmice, although it was a factor that
induced AMPK activation in OE mice. AMPK activation was enhanced following four weeks
of running training and the enhancement was stronger after the running plus hypoxia treat-
ment. The AMPK responses in the R+H groups were up-regulated in OE mice (p<0.01), but
down-regulated in KO mice (p<0.05) of AMPKa2, compared to the R+H group of WT mice
(Fig 1B and 1C).
Fig 1. AMPKα2 protein content (Section A) in muscle of wild-type (WT), over expression (OE), knockout
(KO) mice and AMPKα Thr172 phosphorylation (Section B) in the control (C), running (R), hypoxia (H), and
running + hypoxia (R+H) groups of the three geno-type mice. Data are presented as mean±SD (Section C). *
significantly different from the control group, p<0.05; ** p<0.01. # significantly different from the same group
in WT, p<0.05; ## p<0.01. WC =WT control, WR =WT running, OC = OE control, OR = OE running, KC = KO
control, KR = KO running, WH =WT hypoxia, WRH =WT running + hypoxia, OH = OE hypoxia, ORH = OE
running + hypoxia, KH = KO hypoxia, and KRH = KO running + hypoxia.
doi:10.1371/journal.pone.0122593.g001
AMPKα2 and PPARα in Muscle
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The changes of nuclear PPARα protein expression in muscle lysates
In normoxia, the nuclear PPARα protein was not significantly changed by running exercise in
WTmice (Fig 2, WT). The same result was observed in OE and KOmice (Fig 2A, OE and KO).
In hypoxia, the protein was increased by the treadmill running for 17% (p<0.05) in WTmice
(Fig 2B, WT). An increase (50%, P<0.05) was observed in OE mice in the hypoxia condition,
but the increase was not further changed by the running plus hypoxia treatment (Fig 2B, OE).
The protein expressions were significantly lower in C and R+H groups of KOmice compared
with those in WT (Fig 2B, KO). These results suggest that the PPARα protein may be increased
in muscle by four weeks of hypoxia training. The increase is dependent on AMPK activation.
The change of MCADmRNA level in muscle lysates
The MCADmRNA expression in the skeletal muscle was significantly increased by 2 and 2.39
times after four weeks of R or R+H intervention in WTmice, respectively, but hypoxia alone
did not change MCADmRNA level significantly. After the R+H intervention, OE mice had a
similar level of MCADmRNA expression but KO mice showed a lower level, compared with
that of WT. These results suggest that MCADmRNA expression after intermittent hypoxic
training may be controlled via an AMPKα2-dependent manner (Fig 3).
Discussion
PPAR and AMPK have been the subject of intense investigations in molecular biology, physiol-
ogy, and pharmacology since they are critical regulators of fatty acid oxidation [29–31] and
Fig 2. Nuclear PPARα protein content (Section A) in muscle of wild-type (WT), over expression (OE),
knockout (KO) mice of the control (C), running (R), hypoxia (H), and running + hypoxia (R+H) groups. Data
are presented as mean±SD (Section B). * significantly different from the control group, p<0.05; ** p<0.01. #
significantly different from the same group in WT, p<0.05; ## p<0.01. WC =WT control, WR =WT running,
OC = OE control, OR = OE running, KC = KO control, KR = KO running, WH =WT hypoxia, WRH =WT
running + hypoxia, OH = OE hypoxia, ORH = OE running + hypoxia, KH = KO hypoxia, and KRH = KO
running + hypoxia.
doi:10.1371/journal.pone.0122593.g002
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may be involved to modulate metabolic risk factors, such as dyslipidemia, obesity, and type 2
diabetes [6,32,33]. From the perspective of metabolic regulation, AMPK responds to intracellu-
lar ATP depletion, while PPARα induces the expression of genes coding for enzymes and pro-
teins involved in increasing cellular ATP yields [34]. It is logical to deduce that there would be
a relationship between AMPK and PPARα. However, there was a paucity of research relating
to the possible relationship in vivo. Therefore, the PPARα expression in skeletal muscles from
AMPKα2 OE, AMPKα2 KO, and corresponding WTmice after intermittent hypoxic training
were examined for the first time in the present study.
Four weeks of exercise training or intermittent hypoxic treatment alone did not make any
change in the nuclear PPARα protein content. This result was supported by the short-term
(shorter than four weeks) exercise studies in human skeletal muscle [35,36], while it was differ-
ent to the long-term exercise studies, in which 6–12 weeks of exercise training achieved signifi-
cant increases in PPARα protein or PPARαmRNA in human skeletal muscle [37,38] or in rat
cardiac muscle [13]. These results suggested that the change in PPARα protein expression in
muscle tissues might need a longer duration. Different to the separate effects of exercise or hyp-
oxia alone, however, the four-week combined R+H training increased PPARα nuclear protein
content and its target gene MCADmRNA level in skeletal muscles of WT mice significantly.
This outcome supports the hypothesis of the present study.
It has been well documented that the higher expression of PPARα had been thought to stim-
ulate lipid metabolism in tissues [39] and the PPARα target gene MCAD is one of four differ-
ent chain-length-specific enzymes that catalyze the initial reaction in the mitochondrial fatty
acid β-oxidation cycle [40]. Substrates for MCAD include medium-chain length (C6–C12)
acyl-CoA thioesters derived from (i) medium-chain fatty acids that enter mitochondria by dif-
fusion, (ii) products of mitochondrial β-oxidation of saturated and unsaturated long-chain
fatty acids, and (iii) products of peroxisomal β-oxidation of long-chain and very long-chain
fatty acids. Because these diverse pathways of fatty acid oxidation converge at this point,
Fig 3. MCADmRNA in C, R, H, R+H groups of the three geno-typemice. * significantly different from the
control group, p<0.05; ** p<0.01. # significantly different from the same group in WT, p<0.01; ## p<0.01.
doi:10.1371/journal.pone.0122593.g003
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MCAD catalyzes a pivotal step in cellular fatty acid metabolism. Thus, it seemed reasonable to
think that the intermittent hypoxic training could be used as a potential treatment for fat loss.
However, future studies are needed to test this possibility.
When skeletal muscles face physiological challenges (e.g., exercise and hypoxia), AMPK be-
comes activated in response to changes in cellular energy status and serves to inhibit ATP-con-
suming pathways and activate pathways involved in carbohydrate and fatty acid metabolism to
restore ATP levels [17]. It has been reported that the AMPKα2 was much more abundant than
the AMPKα1 in skeletal muscles [41] and the actions of AMPK in skeletal muscle tissues were
mediated mainly through the AMPKα2 isoform [25], even though AMPK was also activated
via the phosphorylation of its α1 subunit. To explore whether AMPKα2 were involved in the
regulation of PPARα after the four-week intermittent hypoxic training, we measured PPARα
protein, its target gene MCADmRNA, and p-AMPKα. As the results, the intermittent hypoxic
training achieved a much significant increase in AMPK activation in WT muscles than that of
the exercise training or intermittent hypoxia alone. This observation is in agreement with pre-
vious studies, in which the p-AMPKα content in the gastrocnemius muscle was increased by
2.5 times after six weeks of swimming plus hypoxia intervention in lean Zucker rats, but swim
training and hypoxia alone did not change the p-AMPKα content [42]. Moreover, compared
the changes in p-AMPKα among three genotypes of mice following the intermittent hypoxic
training, we found that the OE mice showed a higher value, while the KO mice a lower value
than that of the WT mice. Therefore, the intermittent hypoxic training induced an increase in
AMPK activation significantly affected by overexpression and knockout of the AMPKα2-iso-
form. Meanwhile, our findings indicated that overexpression of the α2-isoform was associated
with 25% higher and knockout of the α2-isoform was associated with 33% lower PPARα pro-
tein content in muscles of the R+H group, compared with that of WT. Likewise, the changes of
MCADmRNA level in skeletal muscles of the R+H group followed a similar trend as that of
PPARα protein content in OE or KO mice, respectively. In summary, it is reasonable to deduce
the hypoxic training approach elicited a profound increase in AMPK activation and induced
PPARα nuclear protein expression, which occurred via an AMPKα2 isoform dependent man-
ner. This result supports the hypothesis of our study.
Previous studies [6,21], but not all [20,22,23], agreed with our observation about AMPK ac-
tivation impacting positively on PPARα. Some studies demonstrated that muscle AMPK acti-
vation by AICAR induced mRNA expression of PPARα target genes [6,21]. Conversely, other
studies have also provided evidence that activated AMPK by AICAR robustly inhibited PPARα
transcriptional activity [20,22,23]. In addition, it has been reported that AMPK, independently
of AMPK activity, activated PPARα by directly binding of AMPKα to the PPARα ligand-bind-
ing domain [20]. Collectively, different tissues and study designs might lead to this conflicting
situation. The existing investigations have mostly carried out by cultured cells in vitro and used
AICAR as the AMPK activator. And yet, little information on the relationship of AMPK and
PPARα in vivo has been obtained from animal or human studies in which intermittent hypoxic
training was employed as the AMPK activator. Indeed, our present study has indicated that
PPARα protein expression in mouse skeletal muscle was increased by four weeks of intermit-
tent hypoxic training and the increase was associated with AMPK activation occurred via an
AMPKα2 isoform dependent manner, but the mechanisms were not examined in this study.
Further studies are needed to elucidate the molecule signaling role in this change.
It is important to acknowledge the limitations of our study, we did not assess PPARδ, which
is also abundant in skeletal muscle. Similar to PPARα, PPARδ regulates fatty acid catabolism
and shares the common target gene of MCAD with PPARα [43]. Exercise, in both acute and
prolonged forms, increased the expression of PPARδ in skeletal muscle [44,45]. In addition, we
did not investigate the mRNA changes of other PPARα-regulated target genes except for
AMPKα2 and PPARα in Muscle
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MCAD. Therefore, it would be desirable to assess PPARδ expression in parallel with PPARα
and the mRNA changes of other PPAR α-regulated target genes in future studies. New evi-
dence from the additional experiments would give more comprehensive insights into the inter-
mittent hypoxic training-induced benefits on fatty acid catabolism.
In conclusion, the major findings of this study were that four weeks of intermittent hypoxic
training significantly increased nuclear PPARα protein and the increase was associated with
AMPK activation via an AMPKα2 isoform dependent manner. More studies are needed to
deeply understand the possible effects of this training model on promoting fatty acid oxidation.
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